The Future of Medicine Shaped
by Cutting-Edge Cell Design Technology
The Research Institute for Cell Design Medical Science (RICeD) aims to become an international research and development center that successively creates seeds for the next-generation cell and gene therapies, through innovative cell design technologies, which are core strength of Yamaguchi University. RICeD also aims to promote the practical application of cutting-edge immunotherapy and genome medicine based on our innovative technologies, to develop treatments for intractable diseases such as cancer and genetic diseases, and to apply and verify these innovative therapies in companion animals. By creating an active cycle in which knowledge gained in humans and companion animals is fed back to each other, RICeD will endeavor to form a drug discovery ecosystem through the social implementation of the created technologies, contribute to local communities and foster human resources through the creation of industries, and extend the healthy lifespan of both humans and companion animals.
- ALL
- News
- Thesis
- Recruiting
News
2026.10.29
*Announcement* An In-House Seminar Will Be Held on Wednesday, November 25
News
2026.10.28
*Announcement* Joint Seminar to Be Held on Tuesday, December 15
News
2026.10.23
*Announcement*Best Poster Award Received
News
2026.10.19
Development Project of an “Index Finger Movement Quantitative Evaluation System” to Visualize Therapeutic Effects on Neurological Disorders Selected for FY2026 Yamaguchi Industry Innovation Acceleration Subsidy [Advance]— Industry-Academia-Government Collaborative Medical Device Development by Professor Takeshita (Department of Neuromuscular Therapeutics / Research Institute for Cell Design Medical Science), Ube Information Systems Co., Ltd., and University-Launched Startup ADDVEMO Inc. —
News
2026.10.15
*Announcement* An In-House Seminar Will Be Held on Monday, January 18
News
2026.10.14
*Announcement* We will be holding a seminar with a guest speaker on Wednesday, December 9.
News
2026.10.13
*Announcement* November 28 (Sat): Symposium “The 9th Multilevel Systems Medicine Symposium”
News
2026.10.10
*Article Published* Article Published in the Ube Nippo
Thesis
2026.09.25
Discovery of a Novel Genetic Variant Associated with Multiple System Atrophy (MSA)
Thesis
2026.08.25
Chemical and Structural Engineering of Guide RNAs for Precision Genome Editing: From Design Principles to Clinical Applications
Thesis
2026.08.18
Frozen–thawed allogeneic fibroblast cell sheets enhance anastomotic healing in a rat colonic anastomotic leakage model
Thesis
2026.05.25
Extracellular vesicle microRNAs from human bone marrow MSCs suppress fibrogenesis of hepatic stellate cells by downregulation of RhoA signaling
Thesis
2026.05.18
Incidence and risk factors of acute blood pressure drops during circular-array pulsed-field ablation for pulmonary vein isolation
Thesis
2026.05.15
Explainable AI-Driven Identification of Multimodal Biomarkers for Early Prediction of Cognitive Decline
Thesis
2026.05.14
[Review] Elucidating the Mechanism of Inflammatory Amplification in Kawasaki Disease: The Role of the IL-33/ST2 Signaling Pathway
Thesis
2026.05.08
miR-765 induces angiogenesis by inhibiting dipeptidyl peptidase 4 and increasing fibroblast growth factor 2
The article could not be found.
News
2026.10.29
*Announcement* An In-House Seminar Will Be Held on Wednesday, November 25
News
2026.10.28
*Announcement* Joint Seminar to Be Held on Tuesday, December 15
News
2026.10.23
*Announcement*Best Poster Award Received
News
2026.10.19
Development Project of an “Index Finger Movement Quantitative Evaluation System” to Visualize Therapeutic Effects on Neurological Disorders Selected for FY2026 Yamaguchi Industry Innovation Acceleration Subsidy [Advance]— Industry-Academia-Government Collaborative Medical Device Development by Professor Takeshita (Department of Neuromuscular Therapeutics / Research Institute for Cell Design Medical Science), Ube Information Systems Co., Ltd., and University-Launched Startup ADDVEMO Inc. —
News
2026.10.15
*Announcement* An In-House Seminar Will Be Held on Monday, January 18
News
2026.10.14
*Announcement* We will be holding a seminar with a guest speaker on Wednesday, December 9.
News
2026.10.13
*Announcement* November 28 (Sat): Symposium “The 9th Multilevel Systems Medicine Symposium”
News
2026.10.10
*Article Published* Article Published in the Ube Nippo
About RICeD
Request for Donations to RICeD
We are promoting the development of cutting-edge cancer immunotherapy to cure many patients.
We are also working to extend the healthy lifespan of both humans and companion animals by applying the world’s first genome editing technology to the treatment of genetic diseases in companion animals and applying the results to human medicine,
We are also working to extend the healthy lifespan of both humans and companion animals by applying the results of our research to human medicine.We sincerely ask for your support to achieve these goals and to continue to promote the practical application of our research results in society.
ー Follow us! ー
